The Optimal Dosage of Rocuronium for Intraoperative Neuromonitoring During Thyroid Surgery
Launched by KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL · Feb 26, 2015
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Recurrent laryngeal nerve (RLN) palsy is the most common and serious complication after thyroid surgery, and ranks among the leading reasons for medicolegal litigation of surgeons. Intraoperative neuromonitoring (IONM) are being applied to prevent RLN injury during thyroid surgery. IONM has been used as a means not only to localize and identify the RLN, but also to predict cord function and elucidate the surgical pitfalls during preparation of RLN.
Muscle relaxant is necessary for general anesthesia; it can facilitate tracheal intubation and stable conditions for surgery. However, the use ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of thyroid tumor
- Exclusion Criteria:
- • neuromuscular disease
About Kaohsiung Medical University Chung Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital is a leading healthcare institution in Taiwan, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, the hospital leverages its extensive expertise in various medical disciplines, state-of-the-art facilities, and a multidisciplinary team of professionals to conduct rigorous clinical studies. Committed to ethical standards and patient safety, the hospital collaborates with academic institutions and industry partners to facilitate groundbreaking research that contributes to the global medical community and enhances treatment options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaohsiung, , Taiwan
Patients applied
Trial Officials
I-Chen Lu, M.D.
Study Chair
Department of Anesthesiology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials